SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-261221
Filing Date
2023-10-24
Accepted
2023-10-24 09:00:00
Documents
51
Period of Report
2023-10-24
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d496165d8k.htm   iXBRL 8-K 26689
2 EX-99.1 d496165dex991.htm EX-99.1 36263
6 GRAPHIC g496165ex99_1p10g1.jpg GRAPHIC 301807
7 GRAPHIC g496165ex99_1p11g1.jpg GRAPHIC 200984
8 GRAPHIC g496165ex99_1p12g1.jpg GRAPHIC 213894
9 GRAPHIC g496165ex99_1p13g1.jpg GRAPHIC 199229
10 GRAPHIC g496165ex99_1p14g1.jpg GRAPHIC 292209
11 GRAPHIC g496165ex99_1p15g1.jpg GRAPHIC 270206
12 GRAPHIC g496165ex99_1p16g1.jpg GRAPHIC 308805
13 GRAPHIC g496165ex99_1p17g1.jpg GRAPHIC 209213
14 GRAPHIC g496165ex99_1p18g1.jpg GRAPHIC 248731
15 GRAPHIC g496165ex99_1p19g1.jpg GRAPHIC 135089
16 GRAPHIC g496165ex99_1p1g1.jpg GRAPHIC 451663
17 GRAPHIC g496165ex99_1p20g1.jpg GRAPHIC 248550
18 GRAPHIC g496165ex99_1p21g1.jpg GRAPHIC 200812
19 GRAPHIC g496165ex99_1p22g1.jpg GRAPHIC 269260
20 GRAPHIC g496165ex99_1p23g1.jpg GRAPHIC 259869
21 GRAPHIC g496165ex99_1p24g1.jpg GRAPHIC 137692
22 GRAPHIC g496165ex99_1p25g1.jpg GRAPHIC 169874
23 GRAPHIC g496165ex99_1p26g1.jpg GRAPHIC 142810
24 GRAPHIC g496165ex99_1p27g1.jpg GRAPHIC 380574
25 GRAPHIC g496165ex99_1p28g1.jpg GRAPHIC 222700
26 GRAPHIC g496165ex99_1p29g1.jpg GRAPHIC 354992
27 GRAPHIC g496165ex99_1p2g1.jpg GRAPHIC 764758
28 GRAPHIC g496165ex99_1p30g1.jpg GRAPHIC 237780
29 GRAPHIC g496165ex99_1p31g1.jpg GRAPHIC 256370
30 GRAPHIC g496165ex99_1p32g1.jpg GRAPHIC 147358
31 GRAPHIC g496165ex99_1p33g1.jpg GRAPHIC 275353
32 GRAPHIC g496165ex99_1p34g1.jpg GRAPHIC 300920
33 GRAPHIC g496165ex99_1p35g1.jpg GRAPHIC 184008
34 GRAPHIC g496165ex99_1p36g1.jpg GRAPHIC 604916
35 GRAPHIC g496165ex99_1p37g1.jpg GRAPHIC 320957
36 GRAPHIC g496165ex99_1p38g1.jpg GRAPHIC 309727
37 GRAPHIC g496165ex99_1p3g1.jpg GRAPHIC 241571
38 GRAPHIC g496165ex99_1p4g1.jpg GRAPHIC 251297
39 GRAPHIC g496165ex99_1p5g1.jpg GRAPHIC 327604
40 GRAPHIC g496165ex99_1p6g1.jpg GRAPHIC 277970
41 GRAPHIC g496165ex99_1p7g1.jpg GRAPHIC 250966
42 GRAPHIC g496165ex99_1p8g1.jpg GRAPHIC 294689
43 GRAPHIC g496165ex99_1p9g1.jpg GRAPHIC 198338
  Complete submission text file 0001193125-23-261221.txt   14618252

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA agle-20231024.xsd EX-101.SCH 2846
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE agle-20231024_lab.xml EX-101.LAB 18759
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE agle-20231024_pre.xml EX-101.PRE 11708
45 EXTRACTED XBRL INSTANCE DOCUMENT d496165d8k_htm.xml XML 3550
Mailing Address 221 CRESCENT STREET BUILDING 17, SUITE 102B WALTHAM MA 02453
Business Address 221 CRESCENT STREET BUILDING 17, SUITE 102B WALTHAM MA 02453 6176515940
Aeglea BioTherapeutics, Inc. (Filer) CIK: 0001636282 (see all company filings)

IRS No.: 464312787 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37722 | Film No.: 231341273
SIC: 2834 Pharmaceutical Preparations